Rayont Inc (RAYT) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket
 


Rayont Inc   (RAYT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Rayont Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Rayont Inc 's ROA in the third quarter of 2023?
Rayont Inc achieved a return on average assets (ROA) of 6.9 % in its third quarter of 2023, this is above RAYT's average return on assets of -59.16%.
Rayont Inc assets over the 12 months ending in its third quarter of 2023 are valued at $10 million

ROA fell compared to the second quarter of 2023, despite the net income growth of % from the second quarter of 2023.

However, within the Healthcare sector 111 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2023 from 858 to 1052.

What is ROA?



Return On Assets (Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
(Jun 30 2022)
IV. Quarter
(Mar 31 2022)
III. Quarter
Y / Y Total Assets Change 20.27 % 1.45 % 13.85 % 66.96 % 50.57 %
Y / Y Net Income Change - - - - -43.67 %
Net Income (TTM) in million 1 1 1 0 -1
Return On Assets (TTM) 6.9 % 10.73 % 10.29 % 2.56 % -9.33 %
RAYT's Total Ranking # 1052 # 858 # 803 # 2195 # 4000
Total Assets (TTM) in million 10 8 9 14 8
Seq. Total Assets Change 22.96 % -10.12 % -36.73 % 72.01 % 3.72 %
Seq. Net Income Change - - -35.65 % 866.4 % -



Return On Assets Company Ranking
Within: No.
Industry # 5
Sector # 112
Overall # 1034

Return On Assets Statistics
High Average Low
10.29 %
-59.16 %
-532.43 %
(Sep 30 2022)   (Jun 30 2018)





Financial Statements
Rayont Inc 's Assets $ 10 million RAYT's Balance sheet
Rayont Inc 's Income $ 0 million Quarterly RAYT's Income Statement
RAYT's Income by Division See RAYT's Income by Division



Annual Return On Assets (Jun 30 2022)
FY 2022
(Jun 30 2021)
FY 2021
(Sep 30 2020)
FY 2020
(Sep 30 2019)
FY 2019
(Sep 30 2018)
FY 2018
Y / Y Total Assets Change 66.96 % 160.79 % 226.41 % 15363.43 % -87.22 %
Total Assets in million 14 9 3 1 0
Y / Y Net Income Change -36.22 % - - - -
Net Income in million 0 0 0 -1 0
Annual Return On Assets 1.73 % 4.52 % -7.04 % -126.45 % -2874.25 %




Comment on RAYT's ROA in the fiscal year ending 2022
In the fiscal year 2022 Rayont Inc 's ROA decreased compared to previous year to 1.73 %, due to deterioration of net income -36.22 % to $0.24 million, from $0.38 million a year ago, as RAYT's assets were $14.19 million.


More Return On Assets Ratios
RAYT's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RAYT's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RAYT's Competitors
Subscribers only: Roa for Rayont Inc 's Suppliers
Subscribers only: Return On Assets for RAYT's Customers

You may also want to know
RAYT's Roi RAYT's Inventory Turnover Ratio RAYT's Growth Rates RAYT's Dividend Comparisons
RAYT's Profitability Ratios RAYT's Asset Turnover Ratio RAYT's Dividend Growth
RAYT's Roe RAYT's Valuation Ratios RAYT's Financial Strength Ratios RAYT's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA
Vertex Pharmaceuticals Inc  18.78 %
Moderna Inc   18.75 %
Innoviva Inc   18.01 %
Siga Technologies Inc  17.95 %
Edwards Lifesciences Corporation  17.51 %
Iradimed Corporation  17.38 %
Chemed Corporation  17.29 %
Ironwood Pharmaceuticals inc   17.04 %
Corcept Therapeutics Inc  16.91 %
Fuse Medical Inc   16.89 %
West Pharmaceutical Services Inc   15.75 %
Resmed Inc   15.63 %
Oncotelic Therapeutics Inc   15.51 %
Maravai Lifesciences Holdings Inc   15.19 %
Tenax Therapeutics Inc   15.08 %
Zynex inc   14.91 %
Pfizer Inc  14.85 %
Atrion Corporation  14.83 %
Zoetis Inc   14.74 %
Regeneron Pharmaceuticals Inc   14.66 %
Tao Synergies Inc   14.45 %
Utah Medical Products Inc  14.11 %
Dr Reddy s Laboratories Limited  13.99 %
Hca Healthcare Inc   13.28 %
Pro dex Inc   12.93 %
Agilent Technologies inc   12.76 %
Biogen Inc   12.64 %
Amphastar Pharmaceuticals Inc   12.56 %
United Therapeutics Corporation  12.28 %
One World Products Inc   12.17 %


Date modified: 2026-09-08T15:10:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.